KURE vs. ARKG ETF Comparison

Comparison of KraneShares MSCI All China Health Care Index ETF (KURE) to ARK Genomic Revolution Multi-Sector ETF (ARKG)
KURE

KraneShares MSCI All China Health Care Index ETF

KURE Description

The investment seeks to provide investment results that, before fees and expenses, track the price and yield performance of the MSCI China All Shares Health Care Index (the "underlying index"). The fund will invest at least 80% of its total assets in components of the underlying index, depositary receipts, including American depositary receipts, representing such components and securities underlying depositary receipts in the underlying index. The underlying index is a free float adjusted market capitalization weighted index designed to track the equity market performance of Chinese companies engaged in the healthcare sector. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$14.76

Average Daily Volume

10,425

Number of Holdings *

2

* may have additional holdings in another (foreign) market
ARKG

ARK Genomic Revolution Multi-Sector ETF

ARKG Description Companies within ARKG are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business. The companies held in ARKG may develop, produce or enable: CRISPR Targeted Therapeutics Bioinformatics Molecular Diagnostics Stem Cells Agricultural Biology ARKG will be concentrated in issuers in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry. ARKG is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund’s investment theme of the genomics revolution.

Grade (RS Rating)

Last Trade

$23.97

Average Daily Volume

2,338,689

Number of Holdings *

37

* may have additional holdings in another (foreign) market
Performance
Period KURE ARKG
30 Days 0.05% -15.47%
60 Days -5.37% -24.23%
90 Days 2.34% -17.50%
12 Months -27.54% -15.20%
0 Overlapping Holdings
Symbol Grade Weight in KURE Weight in ARKG Overlap
KURE Overweight 2 Positions Relative to ARKG
Symbol Grade Weight
BGNE C 4.55%
LEGN F 1.87%
KURE Underweight 37 Positions Relative to ARKG
Symbol Grade Weight
CRSP F -7.23%
TWST C -6.83%
RXRX D -5.57%
EXAS F -5.28%
SDGR F -4.54%
IONS D -4.52%
ACCD F -3.98%
NTLA D -3.73%
BEAM F -3.59%
ARCT D -3.56%
TXG F -3.54%
TDOC F -3.5%
CDNA C -3.43%
MRNA A -3.21%
DNA F -3.18%
VCYT D -2.96%
VEEV D -2.88%
VRTX C -2.73%
NRIX D -2.52%
ADPT F -2.13%
MASS F -1.74%
INCY D -1.62%
QSI D -1.59%
VERV F -1.45%
CMPS C -1.31%
PACB F -1.29%
REGN C -1.22%
PATH F -1.16%
ABSI B -1.13%
CERS D -1.08%
AMGN B -1.07%
PRME F -1.01%
RPTX F -0.66%
PSNL B -0.63%
BFLY F -0.62%
NTRA A -0.58%
GH F -0.48%
Compare ETFs